Decreased acid-labile subunit (ALS) levels by endotoxin in vivo and by interleukin-1β in vitro
- 1 June 1998
- journal article
- Published by Elsevier in Growth Hormone & IGF Research
- Vol. 8 (3) , 217-223
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Effect of the somatostatin analog, octreotide, and of other hormones on the release of the acid-labile subunit of the 150 kDa complex by rat hepatocyte in primary cultureEuropean Journal of Endocrinology, 1997
- Critical illness is associated with low circulating concentrations of insulin-like growth factors-I and -II, alterations in insulin-like growth factor binding proteins, and induction of an insulin-like growth factor binding protein 3 proteaseCritical Care Medicine, 1996
- Wasting in the acquired immune deficiency syndrome is associated with multiple defects in the serum insulin‐like growth factor systemClinical Endocrinology, 1996
- High molecular weight insulin-like growth factor binding protein complexJournal of Biological Chemistry, 1989
- Somatomedins: Chemical and functional characteristics of the different molecular formsJournal of Endocrinological Investigation, 1989
- Characterization of the Acid-Labile Subunit of the Growth Hormone-Dependent Insulin-Like Growth Factor Binding Protein Complex*The Journal of Clinical Endocrinology & Metabolism, 1988
- 1 Biological and immunological properties of insulin-like growth factors (IGF) I and IIClinics in Endocrinology and Metabolism, 1984
- The Somatomedin C Binding Protein: Evidence for a Heterologous Subunit Structure*The Journal of Clinical Endocrinology & Metabolism, 1980
- Demonstration of Specific Plasma Protein Binding Sites For SomatomedinThe Journal of Clinical Endocrinology & Metabolism, 1977
- Binding of nonsuppressible insulinlike activity to human serumArchives of Biochemistry and Biophysics, 1975